Business Description
SeaStar Medical Holding Corp
NAICS : 325412
SIC : 2834
ISIN : US81256L1044
Share Class Description:
ICU: Ordinary SharesDescription
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | -1.99 | |||||
Debt-to-Equity | -0.46 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -14.7 | |||||
3-Year FCF Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | 62.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.48 | |||||
9-Day RSI | 44.26 | |||||
14-Day RSI | 44.64 | |||||
6-1 Month Momentum % | -60.79 | |||||
12-1 Month Momentum % | 22.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.24 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -55.4 | |||||
Shareholder Yield % | -23.01 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -860.94 | |||||
ROIC % | -205.2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.87 | |||||
EV-to-EBITDA | -0.87 | |||||
EV-to-FCF | -2.36 | |||||
Earnings Yield (Greenblatt) % | -114.94 | |||||
FCF Yield % | -50.97 |